RxDoctor Payments Data

Daniel Roshan, MD

Pain Medicine · Santa Barbara, CANPI 1760825665

Payments from drug & device makers

$12,879in general payments, 2019–2025

Across 264 payments — averaging $48.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$3K
  • Boston Scientific$2K
  • Vertos Medical, Inc.$2K
  • Nevro Corp.$2K
  • Medtronic$988
  • Relievant Medsystems, Inc.$976
  • plus $2K from 14 others
$16in research payments, 2019–2025

Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$16

What the payments were for

  • Consulting fees$8637%
  • Travel & lodging$2,17617%
  • Food & beverage$9,84076%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,879 in reported general payments places this provider in the 80th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California

Medicare billing

Part B allowed, 2024
$33,221
Medicare patients
140
Services billed
267

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$496
Gabapentin42$475
Cephalexin25$252
Cyclobenzaprine Hcl29$152
Meloxicam53$105
Duloxetine Hcl14$67

Paid to pharmacies, not to this prescriber.

Other pain medicine in Santa Barbara

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →